Improving social behaviors in individuals with genetic intellectual and developmental disabilities
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
['FUNDING_R01'] · RUSH UNIVERSITY MEDICAL CENTER · NIH-10886616
This study is looking at how to make mental health support better for people with intellectual and developmental disabilities, especially after the challenges brought on by COVID-19, by finding new ways to help them communicate and interact positively with others.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUSH UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10886616 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing access to mental and behavioral health services for individuals with syndromic intellectual and developmental disabilities (IDDs), particularly in the wake of COVID-19 disruptions. The project aims to adapt existing behavior therapy techniques to better suit the unique needs of this vulnerable population, many of whom face significant communication challenges. By utilizing a person-centered approach, the research will explore effective strategies to replace challenging behaviors with positive social interactions. The goal is to create tailored interventions that can be implemented in community settings to improve the quality of life for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 0-11 and 21+ years diagnosed with syndromic IDDs, such as Angelman Syndrome or 22q13 deletion syndrome.
Not a fit: Patients without intellectual or developmental disabilities, or those not diagnosed with syndromic IDDs, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved social communication and behavior in individuals with syndromic IDDs, enhancing their overall well-being and integration into the community.
How similar studies have performed: Previous research has shown promise in adapting behavioral therapies for individuals with IDDs, suggesting that this approach could yield beneficial outcomes.
Where this research is happening
CHICAGO, UNITED STATES
- RUSH UNIVERSITY MEDICAL CENTER — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VALLURIPALLI SOORYA, LATHA — RUSH UNIVERSITY MEDICAL CENTER
- Study coordinator: VALLURIPALLI SOORYA, LATHA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: 22q13 deletion syndrome, Angelman Syndrome